0.3802
price down icon5.02%   -0.0201
after-market 시간 외 거래: .36 -0.0202 -5.31%
loading
전일 마감가:
$0.4003
열려 있는:
$0.3932
하루 거래량:
253.12K
Relative Volume:
1.08
시가총액:
$29.80M
수익:
-
순이익/손실:
$-68.80M
주가수익비율:
-0.325
EPS:
-1.17
순현금흐름:
$-59.06M
1주 성능:
+8.13%
1개월 성능:
-12.86%
6개월 성능:
-32.96%
1년 성능:
-57.04%
1일 변동 폭
Value
$0.3729
$0.4081
1주일 범위
Value
$0.3195
$0.4175
52주 변동 폭
Value
$0.257
$1.33

Passage Bio Inc Stock (PASG) Company Profile

Name
명칭
Passage Bio Inc
Name
전화
(267) 866-0312
Name
주소
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Name
직원
60
Name
트위터
@passage_bio
Name
다음 수익 날짜
2025-03-04
Name
최신 SEC 제출 서류
Name
PASG's Discussions on Twitter

PASG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PASG
Passage Bio Inc
0.3802 29.80M 0 -68.80M -59.06M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-29 재개 Wedbush Outperform
2024-09-03 개시 Rodman & Renshaw Buy
2022-03-08 다운그레이드 JP Morgan Overweight → Neutral
2022-01-19 다운그레이드 Goldman Buy → Neutral
2021-07-01 개시 Raymond James Outperform
2021-06-15 개시 BTIG Research Buy
2021-03-04 업그레이드 Goldman Neutral → Buy
2021-02-04 개시 Guggenheim Buy
2021-01-25 개시 Wedbush Outperform
2021-01-04 업그레이드 JP Morgan Neutral → Overweight
2020-12-11 개시 Citigroup Neutral
2020-08-14 다운그레이드 JP Morgan Overweight → Neutral
2020-06-25 다운그레이드 Goldman Buy → Neutral
2020-03-25 개시 Chardan Capital Markets Buy
2020-03-24 개시 Cowen Outperform
2020-03-24 개시 Goldman Buy
2020-03-24 개시 JP Morgan Overweight
모두보기

Passage Bio Inc 주식(PASG)의 최신 뉴스

pulisher
Jun 14, 2025

Passage Bio, Inc. (NASDAQ:PASG) Stake Cut by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

American Battery Technology (NASDAQ:ABAT) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Has $36,000 Stake in Passage Bio, Inc. (NASDAQ:PASG) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Semrush Holdings, Inc. (NASDAQ:SEMR) Shares Purchased by Bank of America Corp DE - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Lumina Gold (OTCMKTS:LMGDF) Trading Down 0.3% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Obsidian Energy (OTCMKTS:OBELF) Shares Up 2.7% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Carbios SAS (OTCMKTS:COOSF) Stock Price Up 5% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Suncrest Bank (OTCMKTS:SBKK) Shares Up 1% – Should You Buy? - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Color Star Technology (NASDAQ:CSCW) Trading 0.5% Higher – Here’s What Happened - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Inventiva (NASDAQ:IVA) Stock Price Up 0.8% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Fury Gold Mines (NYSEAMERICAN:FURY) Stock Price Down 3.2% – Here’s Why - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Nano Magic (OTCMKTS:NMGX) Shares Up 5% – What’s Next? - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Grows Holdings in Passage Bio, Inc. (NASDAQ:PASG) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews

Jun 06, 2025
pulisher
Jun 06, 2025

Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace

Jun 06, 2025
pulisher
Jun 05, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Purchased by Northern Trust Corp - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Has $1.93 Million Stake in Haleon plc (NYSE:HLN) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Passage Bio Adopts Key Proposals at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Position in Talkspace, Inc. (NASDAQ:TALK) - Defense World

May 30, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Increases Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World

May 29, 2025
pulisher
May 21, 2025

VintaBio Showcases Breakthrough Gene Therapy Manufacturing Platform - MyChesCo

May 21, 2025
pulisher
May 20, 2025

Metachromatic Leukodystrophy Pipeline 2025: Groundbreaking - openPR.com

May 20, 2025
pulisher
May 20, 2025

GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Guggenheim Adjusts Price Target for Passage Bio (PASG) | PASG St - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Grows Holdings in Intevac, Inc. (NASDAQ:IVAC) - Defense World

May 20, 2025
pulisher
May 18, 2025

Cabaletta Bio Updates Progress on RESET-Myositis Trial and Regulatory Milestones - MyChesCo

May 18, 2025
pulisher
May 18, 2025

Passage Bio Reports Q1 2025 Financial Results and Highlights Progress in Gene Therapy Development - MSN

May 18, 2025
pulisher
May 18, 2025

Wedbush Issues Pessimistic Estimate for Passage Bio Earnings - Defense World

May 18, 2025
pulisher
May 16, 2025

Gm1 Gangliosidosis Treatment Market in 2025 Detailed Study - openPR.com

May 16, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Has $1.14 Million Stock Holdings in Traeger, Inc. (NYSE:COOK) - Defense World

May 16, 2025
pulisher
May 16, 2025

TransAct Technologies Incorporated (NASDAQ:TACT) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 16, 2025
pulisher
May 16, 2025

Passage Bio, Inc. (NASDAQ:PASG) Shares Acquired by Tower Research Capital LLC TRC - Defense World

May 16, 2025
pulisher
May 16, 2025

Tower Research Capital LLC TRC Acquires 7,927 Shares of The E.W. Scripps Company (NASDAQ:SSP) - Defense World

May 16, 2025
pulisher
May 14, 2025

Braskem Marks 15 Years of I’m green Bio-Based Portfolio with Expanded Production - MyChesCo

May 14, 2025
pulisher
May 14, 2025

Passage Bio Reports Q1 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Wedbush Adjusts Price Target on Passage Bio to $3 From $4, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Passage Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Passage Bio Q1 Income From Operations USD -16.459 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Passage Bio (PASG) Advances Phase 1/2 Trial for PBFT02, Eyes Fut - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Passage BIO, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Passage Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025 - The Manila Times

May 13, 2025
pulisher
May 11, 2025

Passage Bio (PASG) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

2025 Q1 Job Market Report: Quarterly Job Postings Live Declined as Applications Spiked - BioSpace

May 08, 2025
pulisher
May 01, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - MyChesCo

May 01, 2025
pulisher
Apr 30, 2025

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc: A Strategic Portfolio Adjustment - GuruFocus

Apr 30, 2025

Passage Bio Inc (PASG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Passage Bio Inc 주식 (PASG) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
ORBIMED ADVISORS LLC
10% Owner
Jun 26 '25
Sale
0.33
213,257
70,375
6,066,343
ORBIMED ADVISORS LLC
10% Owner
Jun 25 '25
Sale
0.33
138,800
45,804
6,279,600
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):